{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T10:19:14Z","timestamp":1772792354473,"version":"3.50.1"},"reference-count":39,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2006,8,2]],"date-time":"2006-08-02T00:00:00Z","timestamp":1154476800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[2006,11]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Objective\u2002<\/jats:bold> The presence of GH receptor in human skin and its appendages suggests a direct effect of GH on skin characteristics. The skin is usually thin and dry in patients with GH deficiency (GHD). Sheehan's syndrome classically refers to postpartum hypopituitarism and GH is one of the earliest pituitary hormones lost. While severe GHD is a well\u2010established feature of Sheehan's Syndrome, skin characteristics and the effects of GH replacement therapy (GHRT) have been investigated neither in Sheehan's syndrome nor in other disorders of GHD. The aim of this study was to investigate the skin characteristics, including the sebum content, hydration (skin capacitance), transepidermal water loss (TEWL), pH and skin temperature, and particularly the effects of 6\u00a0months of GHRT on these parameters in GH deficient patients with Sheehan's syndrome.<\/jats:p><jats:p><jats:bold>Patients and design\u2002<\/jats:bold> Sixteen severely GH deficient women with Sheehan's syndrome (48\u00b71\u00a0\u00b1\u00a010\u00b79\u00a0years), and 20 age and menopausal status similar women as control subjects were included. Ten patients received recombinant GH for 6\u00a0months (treatment group) and 6 patients received placebo (placebo group) during this period. Skin properties were measured at baseline and after 6\u00a0months of GHRT using noninvasive and well\u2010established measuring methods.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> At baseline the skin capacitance was significantly decreased on the forehead and forearm, and sebum content was significantly decreased on forehead in patients with Sheehan's syndrome compared to control subjects (<jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00\u00b705). In the treatment group there was a significant increase in sebum content on forehead after 6\u00a0months of GHRT compared to the baseline value (<jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00\u00b705). However there were no significant changes in other parameters including sebum content on the forearm, TEWL, Ph, skin capacitance and temperature of both the forearm and forehead. In the placebo group there were no changes in any of the evaluated parameters after 6\u00a0months of treatment compared to baseline values.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> The present study clearly shows that the sebum content on the forehead and skin hydration of the forehead and forearm are significantly decreased in GH deficient patients with Sheehan's syndrome. However 6\u00a0months of GHRT significantly increased only the sebum content on the forehead. These data suggest that GH and\/or IGF\u2010I may have a modulatory role on several skin characteristics<jats:italic>.<\/jats:italic><\/jats:p>","DOI":"10.1111\/j.1365-2265.2006.02631.x","type":"journal-article","created":{"date-parts":[[2006,8,2]],"date-time":"2006-08-02T23:43:41Z","timestamp":1154562221000},"page":"579-585","source":"Crossref","is-referenced-by-count":18,"title":["Investigation of the skin characteristics in patients with severe GH deficiency and the effects of 6\u00a0months of GH replacement therapy: a randomized placebo controlled study"],"prefix":"10.1111","volume":"65","author":[{"given":"Fatih","family":"Tanriverdi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat","family":"Borlu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hulusi","family":"Atmaca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cagdas Atasavun","family":"Koc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kursad","family":"Unluhizarci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serap","family":"Utas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahrettin","family":"Kelestimur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,8,4]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1992.tb02347.x"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.77.6.1671"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.76.2.309"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(94)90245-3"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ghir.2005.03.005"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2005.02283.x"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1500153"},{"key":"e_1_2_5_9_2","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1210\/jcem.84.8.5916","article-title":"The effects of 10 years of recombinant human growth hormone (GH) in adult GH\u2010deficient patients","volume":"84","author":"Gibney J.","year":"1999","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1260467"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.75.5.1368"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1023\/B:PITU.0000023425.20854.8e"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1450147"},{"key":"e_1_2_5_14_2","article-title":"The effects of severe growth hormone deficiency on the skin in patients with sheehan's syndrome","author":"Borlu M.","year":"2006","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1700450118"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.01881"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.83.2.379"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2004.00929.x"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1159\/000211345"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0846.2000.006002092.x"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2003.105"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1159\/000246272"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1991.04520010052006"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1159\/000056341"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1987.tb00805.x"},{"key":"e_1_2_5_26_2","first-page":"219","volume-title":"Textbook of Endocrinology","author":"Thorner M.O.","year":"1992"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1210\/er.2002-0021"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo.143.7.8909"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1210\/edrv.21.4.0404"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1550-8528.1996.tb00511.x"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199007053230101"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0305-4179(02)00208-5"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1159\/000063377"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1566-0702(01)00257-0"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)91543-4"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1993.tb01001.x"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365519109091642"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2000.01141.x"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo.140.9.6957"},{"key":"e_1_2_5_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12616781"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.2006.02631.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.2006.02631.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T23:13:09Z","timestamp":1697238789000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.2006.02631.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8,4]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["10.1111\/j.1365-2265.2006.02631.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.2006.02631.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8,4]]}}}